Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wrist-ankle acupuncture plus oxycodone for moderate-to-severe cancer pain in hepatocellular carcinoma
TCTR20220427002Phase 1Unknown
- Sponsor
- Zhilin Zhou
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in hepatocellular carcinoma (HCC) and cancer pain comparing Wrist-ankle acupuncture + oxycodone with Placebo acupuncture + oxycodone (2 arms). Status: unknown.
02
Drugs
oxycodone
03
Conditions
hepatocellular carcinoma (HCC)cancer pain
Beyond the preview
Go deeper on TCTR20220427002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220427002.